Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Medical Specialties
Sector Health Technology
Employees 1,841
CEO Mr. John E. Adent
Address 620 Lesher Place , Lansing, MI 48912
Phone 1.517.372.9200
Website www.neogen.com

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Neogen Corp. -6.72% 17.62%
Intellia Therapeutics, Inc. -12.14% 465.28%
Neurocrine Biosciences, Inc. 6.47% 7.39%
Zai Lab Ltd. -36.13% 16.43%
Mirati Therapeutics, Inc. 8.04% -5.16%

Statement Summary

as of 4:00 ET PM 10/21/2021
Total Assets (MRQ) 932.1 M
Total Liabilities (MRQ) 76.7 M
Shareholders’ Equity (MRQ) 855.4 M
Total Revenue (Annual) 128.3 M
Net Income (Annual) 17.1 M

Earnings And Estimates

as of 4:00 ET PM 10/21/2021

Current Qtr EPS Estimate 0.17
Current FY EPS Estimate 0.66
Long Term EPS Growth Estimate 10.00
Next Expected Earnings Date 12/20/2021

NEOG vs S&P 500

as of 10/21/2021
Relative To
S&P 500
NEOG
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 10/21/2021
Fiscal Quarter Estimate Actual Surprise
08/2021 0.16 0.16 0.00%
05/2021 0.14 0.15 +8.43%
02/2021 0.13 0.13 -2.60%
11/2020 0.16 0.15 -4.26%
08/2020 0.14 0.15 +9.09%
05/2020 0.15 0.16 +4.20%
02/2020 0.14 0.12 -14.81%
11/2019 0.16 0.16 -0.80%

Financial Strength

as of 4:00 ET PM 10/21/2021
Pre-Tax Margin 16.93
Net Margin -8.25
Operating Margin 16.95
Return On Equity 7.73
Return On Assets 7.08
Inventory Turnover (TTM) 2.63
Sales Growth (MRQ) n/a

Ratios

as of 4:00 PM ET 10/21/2021
Price/Earnings (TTM) 71.63
Price/Book (MRQ) 5.20
Price/Cash Flow (TTM) 56.45
Book Value (MRQ) 7.96
Quick Ratio (MRQ) 9.99
Current Ratio (MRQ) 12.00
Total Debt/Equity (MRQ) 0.00

Short Interest

as of 9:57 AM ET 10/22/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 10/21/2021
Current Qtr
(11/2021)
Next Qtr
(02/2022)
Consensus Estimate $0.17 $0.15
# of Estimates 2 2
High Estimate $0.17 $0.15
Low Estimate $0.17 $0.15
Year Ago EPS $0.15 $0.13
Year Over Year Growth Estimate 13.71% 19.81%
Current Yr
(05/2022)
Next Yr
(05/2023)
Consensus Estimate $0.66 $0.74
# of Estimates 2 2
High Estimate $0.66 $0.74
Low Estimate $0.65 $0.74
Year Ago EPS $0.57 $0.66
Year Over Year Growth Estimate 14.91% 12.98%
Current Qtr
(11/2021)
Next Qtr
(02/2022)
Current Year
(05/2022)
Next Year
(05/2023)
Consensus Estimate $0.17 $0.15 $0.66 $0.74
# of Estimates 2 2 2 2
High Estimate $0.17 $0.15 $0.66 $0.74
Low Estimate $0.17 $0.15 $0.65 $0.74
Year Ago EPS $0.15 $0.13 $0.57 $0.66
Year Over Year Growth Estimate 13.71% 19.81% 14.91% 12.98%

Insider Information Summary

as of 09/30/2021
% Insiders - 0.34%
% Remaining Total Shares - 99.66%
Current 1 Month
Net Insider Transaction 25.93 K 0.00
Shares Bought 47.63 K 0.00
Shares Sold 21.70 K 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Stock Traders New York Stock Exchange Lead

Stocks Mixed as Powell Cautions on Inflation, Taper Plan on Track

Stocks retreat from records Friday as Fed Chair Powell said the central bank was on track to begin tapering the pace of its monthly bond purchases.

WeWork Boom Continues as Startup Raises $760 Million of New Funding

5 Top Gainers for Friday: WeWork, Cleveland-Cliffs, American Express

WeWork, Cleveland-Cliffs, American Express, Phunware and Olin are five top gainers for Friday.

Carvana

Carvana Drops; Complaints Against Car Retailer Reportedly at Issue

The Better Business Bureau has received nearly 900 consumer complaints about Carvana this year, a media report says.

Beyond Meat Lead

Buy the Dip in Beyond Meat Stock? Not So Fast.

Beyond Meat stock is slumping on Friday after slashing its revenue outlook. The charts don't look great -- unless it can reclaim a key level.

Seagate Technology

Seagate Shares Rise on Stronger-Than-Expected Earnings

Seagate Technology shares rose after the disk-drive maker reported stronger-than-expected earnings and buoyant guidance.

Wall Street Lead

Dow, S&P 500 Slide As Fed Chair Powell Cautions on Inflation, Says Taper Plans 'On Track'

Wall Street retreated from fresh record highs Friday as Fed Chair Jerome Powell said the central bank is "on track" to being tapering the pace of its monthly bond purchases.

23andMe Lead

23andMe Stock Drops on Plan to Buy Health Platform Lemonaid

23andMe shares drop after the consumer genetics company definitively agrees to pay $400 million for health platform Lemonaid.

Pfizer vaccine Lead

Pfizer-BioNTech Covid Vaccine Shows Efficacy Above 90% for Kids

Pfizer and BioNTech's children's Covid-19 vaccine should be the topic of discussion when the FDA's vaccine advisory committee meets Tuesday.

Tesla Lead

Tesla Stock Hits Record High, With $1 Trillion Valuation In Sight, After Q3 Earnings Surge

Tesla is now within clear sight of a $1 trillion valuation after shares in the group hit a fresh all-time high following record third quarter earnings earlier this week.

Zoom Five9 Lead

Zoom Video Stock Rises After JPMorgan Upgrade

JPMorgan analyst upgraded Zoom Video and said the videoconferencing app could be a winner in enterprise or B2B communication.